CR8771A - Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 - Google Patents

Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1

Info

Publication number
CR8771A
CR8771A CR8771A CR8771A CR8771A CR 8771 A CR8771 A CR 8771A CR 8771 A CR8771 A CR 8771A CR 8771 A CR8771 A CR 8771A CR 8771 A CR8771 A CR 8771A
Authority
CR
Costa Rica
Prior art keywords
hydroxi
beta
inhibitor
dehydrogenase type
steroid dehydrogenase
Prior art date
Application number
CR8771A
Other languages
English (en)
Inventor
Henriksson Martin
Homan Evert
Johansson Lars
Vallgarda Jerk
Williams Meredith
Bercot Eric
H Fotsch Christopher
Li Aiwen
Cai Guolin
Hungate Randal
Chenguang Yuan Chester
Tegley Christopher
St Jean David
Han Nianhe
Huang Qi
Liu Qingyian
D Bartberger Michael
A Moniz George
J Frizzle Matthew
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0401324A external-priority patent/SE0401324D0/xx
Priority claimed from SE0402509A external-priority patent/SE0402509D0/xx
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of CR8771A publication Critical patent/CR8771A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a compuestos con la formula (I), ( II ), ( III ) o ( IV), en los cuales R1,R2,R3,R4,R5,R6,R7, X y Z son como se define aqui y ademas a composiciones farmaceuticas que comprenden los compuestos, como tambien metodos de uso de los compuestos para el tratamiento de transtornos asociados con la enzima deshidrogenasa 11-B- hidroxiesteroide tipo 1 y para la preparacion de un medicamento que actua sobre la enzima deshidrogenasa 11-b- hidroxiesteroide tipo 1 humana.
CR8771A 2004-05-24 2006-11-24 Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1 CR8771A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0401324A SE0401324D0 (sv) 2004-05-24 2004-05-24 New compounds
SE0402509A SE0402509D0 (sv) 2004-10-15 2004-10-15 New compounds
US65077705P 2005-01-31 2005-01-31

Publications (1)

Publication Number Publication Date
CR8771A true CR8771A (es) 2007-07-24

Family

ID=41717469

Family Applications (2)

Application Number Title Priority Date Filing Date
CR8771A CR8771A (es) 2004-05-24 2006-11-24 Inhibidor de 11-beta-hidroxi esteroide deshidrogenasa tipo 1
CR20120420A CR20120420A (es) 2004-05-24 2012-08-10 Inhibidor de 11-beta-hidroxi exteroide deshidrogenasa tipo 1

Family Applications After (1)

Application Number Title Priority Date Filing Date
CR20120420A CR20120420A (es) 2004-05-24 2012-08-10 Inhibidor de 11-beta-hidroxi exteroide deshidrogenasa tipo 1

Country Status (10)

Country Link
KR (1) KR101296408B1 (es)
CR (2) CR8771A (es)
EC (1) ECSP067108A (es)
HK (1) HK1096095A1 (es)
HR (1) HRP20060456A2 (es)
IL (1) IL179167A (es)
MA (1) MA28662B1 (es)
MX (1) MXPA06013657A (es)
NO (1) NO20065781L (es)
NZ (1) NZ552284A (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302691B6 (cs) 1998-07-08 2011-09-07 Sanofi - Aventis Deutschland GmbH N-Arylamidová sloucenina, zpusob její prípravy, farmaceutický prostredek tuto slouceninu obsahující, tato sloucenina pro použití jako aktivátor a pro použití k terapii nebo profylaxi

Also Published As

Publication number Publication date
NO20065781L (no) 2007-02-08
NZ552284A (en) 2010-01-29
ECSP067108A (es) 2007-05-30
CR20120420A (es) 2012-09-14
IL179167A (en) 2012-01-31
HK1096095A1 (en) 2007-05-25
MA28662B1 (fr) 2007-06-01
IL179167A0 (en) 2007-03-08
KR101296408B1 (ko) 2013-08-13
HRP20060456A2 (en) 2007-03-31
KR20070058382A (ko) 2007-06-08
MXPA06013657A (es) 2007-11-07

Similar Documents

Publication Publication Date Title
SV1999000118A (es) Nuevos derivados de pirazol substituidos ref. lea 33188-sv
AR047529A1 (es) Compuestos de quinolina sustituidos
BRPI0510394A (pt) inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
BRPI0411528A (pt) uso de isomalte como prebiótico
UY31524A1 (es) Nuevos compuestos 010
GT200400092A (es) Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
CR9987A (es) Compuestos de lactama y métodos de uso de los mismos
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
CR9834A (es) [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la ezquizofrenia
GT200500238A (es) Fenilaminotiazoles sustituidos y su uso
PA8632701A1 (es) Compuestos terapeuticos
UY28150A1 (es) Agentes terapeuticos
UY28861A1 (es) Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
UY28144A1 (es) Agentes terapéuticos
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
PA8632601A1 (es) Derivados de pirimidina para tratar el crecimiento celular anómalo
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
CO6321241A2 (es) Derivados de 1,3,4- tiadiazol espiro condensados para la inhibicion de la actividad de quinesina (ksp)
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
PA8855001A1 (es) Monocarbamas
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
UY29134A1 (es) Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones